Outside of clinical trials, pre-licence access in the UK may theoretically occur via the MHRA's Early Access to Medicines Scheme (EAMS), though no such scheme for retatrutide is publicly available at the time of writing
My GLP-1 Tracker and Journal- Weightloss goals-Weekly Goals for weightless on a GLP1 medication: Weekly planner tracker for your GLP1 Medication
Volume of water intragastrically (1 ml/6 s), either to leaking induction, or to a maximal volume of 20 ml, means S.D.) throughout the days after duodenocutaneous fistulas formation in controls saline 5 ml/kg intraperitoneally once daily, drinking water only (12 ml/day/rat), BPC 157 10 g/kg or 10 ng/kg, given intraperitoneally, once daily or perorally, in drinking water (0.16 g/ml or 0.16 ng/ml), L-NAME 5 mg/kg intraperitoneally, once daily, L-arginine 100 mg/kg intraperitoneally, once daily (given alone or together) treated rats
In the DURATION-1 and -5 trials, exenatide once weekly was shown to reduce HbA1c more significantly than twice daily administration (1.9% vs
